CTD Holdings Establishes Second Clinical Trial Site for US Phase I Clinical Study of Trappsol Cyclo? for Treatment of Niemann-Pick Disease Type C

Press/Media: Press / Media

PeriodOct 5 2018

Media coverage

1

Media coverage

  • TitleCTD Holdings Establishes Second Clinical Trial Site for US Phase I Clinical Study of Trappsol Cyclo? for Treatment of Niemann-Pick Disease Type C
    Media name/outletPharmacy Choice
    CountryUnited States
    Date10/5/18
    PersonsDarius Adams